{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:53:29Z","timestamp":1792691609878,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Y24H160074"],"award-info":[{"award-number":["Y24H160074"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY22H160001"],"award-info":[{"award-number":["LY22H160001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802986"],"award-info":[{"award-number":["81802986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008856","name":"Department of Health of Zhejiang Province","doi-asserted-by":"publisher","award":["2020KY589"],"award-info":[{"award-number":["2020KY589"]}],"id":[{"id":"10.13039\/501100008856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,5,26]]},"DOI":"10.1038\/s41388-026-03753-5","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:14:16Z","timestamp":1775578456000},"page":"1756-1770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PIAS4 inhibition induces cell cycle arrest and exhibits a synergistic effect in combination with CDK4\/6 inhibitor in breast cancer treatment"],"prefix":"10.1038","volume":"45","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4506-1213","authenticated-orcid":false,"given":"Lifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-3097","authenticated-orcid":false,"given":"Hongchuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-0407","authenticated-orcid":false,"given":"Zhinong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"3753_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024;74:229\u201363.","journal-title":"CA Cancer J Clinicians"},{"key":"3753_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","volume":"13","author":"B O\u2019Leary","year":"2016","unstructured":"O\u2019Leary B, Finn RS, Turner NC. Treating cancer with selective CDK4\/6 inhibitors. Nat Rev Clin Oncol. 2016;13:417\u201330.","journal-title":"Nat Rev Clin Oncol"},{"key":"3753_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","volume":"37","author":"M \u00c1lvarez-Fern\u00e1ndez","year":"2020","unstructured":"\u00c1lvarez-Fern\u00e1ndez M, Malumbres M. Mechanisms of sensitivity and resistance to CDK4\/6 inhibition. Cancer cell. 2020;37:514\u201329.","journal-title":"Cancer cell"},{"key":"3753_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature08657","volume":"462","author":"Y Galanty","year":"2009","unstructured":"Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature. 2009;462:935\u20139.","journal-title":"Nature"},{"key":"3753_CR5","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1128\/JVI.03055-15","volume":"90","author":"KL Conn","year":"2016","unstructured":"Conn KL, Wasson P, McFarlane S, Tong L, Brown JR, Grant KG, et al. Novel role for protein Inhibitor of activated STAT 4 (PIAS4) in the restriction of herpes simplex virus 1 by the cellular intrinsic antiviral immune response. J Virol. 2016;90:4807\u201326.","journal-title":"J Virol"},{"key":"3753_CR6","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/nar\/gkaa1232","volume":"49","author":"AJ Locke","year":"2021","unstructured":"Locke AJ, Hossain L, McCrostie G, Ronato DA, Fitieh A, Rafique TA, et al. SUMOylation mediates CtIP\u2019s functions in DNA end resection and replication fork protection. Nucleic acids Res. 2021;49:928\u201353.","journal-title":"Nucleic acids Res"},{"key":"3753_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1161\/01.RES.0000076893.70898.36","volume":"92","author":"TH Chun","year":"2003","unstructured":"Chun TH, Itoh H, Subramanian L, I\u00f1iguez-Lluh\u00ed JA, Nakao K. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy. Circul Res. 2003;92:1201\u20138.","journal-title":"Circul Res"},{"key":"3753_CR8","doi-asserted-by":"crossref","unstructured":"Liang M, Cai Z, Jiang Y, Huo H, Shen L, He B. SENP2 promotes VSMC phenotypic switching via myocardin de-SUMOylation. Int J Mol Sci. 2022;23:12637","DOI":"10.3390\/ijms232012637"},{"key":"3753_CR9","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","volume":"100","author":"H-M Chang","year":"2020","unstructured":"Chang H-M, Yeh ET. SUMO: from bench to bedside. Physiol Rev. 2020;100:1599\u2013619.","journal-title":"Physiol Rev"},{"key":"3753_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","volume":"23","author":"ACO Vertegaal","year":"2022","unstructured":"Vertegaal ACO. Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol. 2022;23:715\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3753_CR11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29:946\u201360.","journal-title":"Cell Death Differ"},{"key":"3753_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"3753_CR13","doi-asserted-by":"crossref","unstructured":"Luo N, Zhang K, Li X, Hu Y, Guo L. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer. J Adv Res. 2024;69:313\u201327.","DOI":"10.1016\/j.jare.2024.04.009"},{"key":"3753_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1096\/fj.201700088RR","volume":"32","author":"X Yu","year":"2018","unstructured":"Yu X, Chen H, Zuo C, Jin X, Yin Y, Wang H, et al. Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation. FASEB J. 2018;32:552\u201367.","journal-title":"FASEB J"},{"key":"3753_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/2159-8290.CD-20-1726","volume":"12","author":"Q Li","year":"2022","unstructured":"Li Q, Jiang B, Guo J, Shao H, Del Priore IS, Chang Q, et al. INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors. Cancer Discov. 2022;12:356\u201371.","journal-title":"Cancer Discov"},{"key":"3753_CR16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nprot.2014.053","volume":"9","author":"SV Barysch","year":"2014","unstructured":"Barysch SV, Dittner C, Flotho A, Becker J, Melchior F. Identification and analysis of endogenous SUMO1 and SUMO2\/3 targets in mammalian cells and tissues using monoclonal antibodies. Nat Protoc. 2014;9:896\u2013909.","journal-title":"Nat Protoc"},{"key":"3753_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.741736","volume":"9","author":"B Zhou","year":"2021","unstructured":"Zhou B, Zhu Y, Xu W, Zhou Q, Tan L, Zhu L, et al. Hypoxia stimulates SUMOylation-dependent stabilization of KDM5B [J]. Front Cell Develop Biol. 2021;9:741736.","journal-title":"Front Cell Develop Biol"},{"key":"3753_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003972","volume":"8","author":"X Fan","year":"2021","unstructured":"Fan X, Li Y, Feng Z, Chen G, Zhou J, He M, et al. Nanoprobes-assisted multichannel NIR-II fluorescence imaging-guided resection and photothermal ablation of lymph nodes. Adv Sci. 2021;8:2003972.","journal-title":"Adv Sci"},{"key":"3753_CR19","first-page":"290","volume":"67","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, et al. Breast cancer-major changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA: a cancer J clinicians. 2017;67:290\u2013303.","journal-title":"CA: a cancer J clinicians"},{"key":"3753_CR20","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb (Mass)). 2024;5:100625.","journal-title":"Innov (Camb (Mass))"},{"key":"3753_CR21","doi-asserted-by":"publisher","first-page":"e3000324","DOI":"10.1371\/journal.pbio.3000324","volume":"17","author":"YL Yan","year":"2019","unstructured":"Yan YL, Zhang C, Hao J, Wang XL, Ming J, Mi L, et al. DPPA2\/4 and SUMO E3 ligase PIAS4 opposingly regulate zygotic transcriptional program. PLoS Biol. 2019;17:e3000324.","journal-title":"PLoS Biol"},{"key":"3753_CR22","doi-asserted-by":"publisher","first-page":"W325","DOI":"10.1093\/nar\/gku383","volume":"42","author":"Q Zhao","year":"2014","unstructured":"Zhao Q, Xie Y, Zheng Y, Jiang S, Liu W, Mu W, et al. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res. 2014;42:W325\u2013330.","journal-title":"Nucleic Acids Res"},{"key":"3753_CR23","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1093\/bioinformatics\/btv403","volume":"31","author":"G Beauclair","year":"2015","unstructured":"Beauclair G, Bridier-Nahmias A, Zagury JF, Sa\u00efb A, Zamborlini A. JASSA: a comprehensive tool for prediction of SUMOylation sites and SIMs. Bioinforma. 2015;31:3483\u201391.","journal-title":"Bioinforma"},{"key":"3753_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25700-6","volume":"12","author":"F Dang","year":"2021","unstructured":"Dang F, Nie L, Zhou J, Shimizu K, Chu C, Wu Z, et al. Inhibition of CK1\u03b5 potentiates the therapeutic efficacy of CDK4\/6 inhibitor in breast cancer. Nat Commun. 2021;12:5386.","journal-title":"Nat Commun"},{"key":"3753_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ccell.2018.11.006","volume":"34","author":"Z Li","year":"2018","unstructured":"Li Z, Razavi P, Li Q, Toy W, Liu B, Ping C, et al. Loss of the FAT1 tumor suppressor promotes resistance to CDK4\/6 inhibitors via the Hippo pathway. Cancer cell. 2018;34:893\u2013905.","journal-title":"Cancer cell"},{"key":"3753_CR26","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1128\/MCB.01823-08","volume":"29","author":"L Bockstaele","year":"2009","unstructured":"Bockstaele L, Bisteau X, Paternot S, Roger PP. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation. Mol Cell Biol. 2009;29:4188\u20134200.","journal-title":"Mol Cell Biol"},{"key":"3753_CR27","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","volume":"71","author":"S Kumar","year":"2022","unstructured":"Kumar S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, Sluijter M, Ruano D, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut. 2022;71:2266\u201383.","journal-title":"Gut"},{"key":"3753_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41419-021-04127-3","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen C, Tong X, Chen S, Hu X, Pan B, et al. NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis. 2021;12:842.","journal-title":"Cell Death Dis"},{"key":"3753_CR29","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3390\/ijms23073639","volume":"23","author":"X Shi","year":"2022","unstructured":"Shi X, Du Y, Li S, Wu H. The role of SUMO E3 ligases in signaling pathway of cancer cells. Int J Mol Sci. 2022;23:3639.","journal-title":"Int J Mol Sci"},{"key":"3753_CR30","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41419-018-0845-x","volume":"9","author":"M Ran","year":"2018","unstructured":"Ran M, Chen H, Liang B, Liao W, Jiang J, Huang J, et al. Alcohol-induced autophagy via upregulation of PIASy promotes HCV replication in human hepatoma cells. Cell Death Dis. 2018;9:898.","journal-title":"Cell Death Dis"},{"key":"3753_CR31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.7150\/thno.79688","volume":"13","author":"FL Zhang","year":"2023","unstructured":"Zhang FL, Yang SY, Liao L, Zhang TM, Zhang YL, Hu SY, et al. Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. Theranostics. 2023;13:973\u201390.","journal-title":"Theranostics"},{"key":"3753_CR32","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1038\/s41388-022-02431-6","volume":"41","author":"L Wei","year":"2022","unstructured":"Wei L, Wang W, Yao J, Cui Z, Xu Z, Ding H, et al. PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation. Oncogene. 2022;41:4282\u201394.","journal-title":"Oncogene"},{"key":"3753_CR33","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1002\/jcb.29610","volume":"121","author":"Q Liu","year":"2020","unstructured":"Liu Q, Zhou B, Liao R, Zhou X, Yan X. PIAS4, upregulated in hepatocellular carcinoma, promotes tumorigenicity and metastasis. J Cell Biochem. 2020;121:3372\u201381.","journal-title":"J Cell Biochem"},{"key":"3753_CR34","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/bjc.2013.531","volume":"109","author":"W Chien","year":"2013","unstructured":"Chien W, Lee KL, Ding LW, Wuensche P, Kato H, Doan NB, et al. PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells. Br J Cancer. 2013;109:1795\u2013804.","journal-title":"Br J Cancer"},{"key":"3753_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10549-014-2897-7","volume":"144","author":"AT Alshareeda","year":"2014","unstructured":"Alshareeda AT, Negm OH, Green AR, Nolan C, Tighe P, Albarakati N, et al. SUMOylation proteins in breast cancer. Breast Cancer Res Treat. 2014;144:519\u201330.","journal-title":"Breast Cancer Res Treat"},{"key":"3753_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu J, Peng Y, Wei W. Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends cell Biol. 2022;32:30\u201344.","journal-title":"Trends cell Biol"},{"key":"3753_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5234","volume":"5","author":"AC Bellail","year":"2014","unstructured":"Bellail AC, Olson JJ, Hao C. SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression. Nat Commun. 2014;5:4234.","journal-title":"Nat Commun"},{"key":"3753_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.891580","volume":"12","author":"GL Rampioni Vinciguerra","year":"2022","unstructured":"Rampioni Vinciguerra GL, Sonego M, Segatto I, Dall\u2019Acqua A, Vecchione A, Baldassarre G, et al. CDK4\/6 inhibitors in combination therapies: better in company than alone: a mini review. Front Oncol. 2022;12:891580.","journal-title":"Front Oncol"},{"key":"3753_CR39","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1124\/pharmrev.122.000784","volume":"75","author":"X Cheng","year":"2023","unstructured":"Cheng X, Yang W, Lin W, Mei F. Paradoxes of cellular SUMOylation regulation: a role of biomolecular condensates? Pharmacol Rev. 2023;75:979\u20131006.","journal-title":"Pharmacol Rev"},{"key":"3753_CR40","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1158\/1078-0432.CCR-13-1675","volume":"19","author":"J Rader","year":"2013","unstructured":"Rader J, Russell MR, Hart LS, Nakazawa MS, Belcastro LT, Martinez D, et al. Dual CDK4\/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin Cancer Res. 2013;19:6173\u201382.","journal-title":"Clin Cancer Res"},{"key":"3753_CR41","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/s41416-022-01990-5","volume":"127","author":"IM Schaefer","year":"2022","unstructured":"Schaefer IM, Hemming ML, Lundberg MZ, Serrata MP, Goldaracena I, Liu N, et al. Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4\/6 inhibition in GIST. Br J Cancer. 2022;127:2072\u201385.","journal-title":"Br J Cancer"},{"key":"3753_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.devcel.2005.10.007","volume":"9","author":"K Nacerddine","year":"2005","unstructured":"Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Develop Cell. 2005;9:769\u201379.","journal-title":"Develop Cell"},{"key":"3753_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","volume":"22","author":"S Goel","year":"2022","unstructured":"Goel S, Bergholz JS, Zhao JJ. Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer. 2022;22:356\u201372.","journal-title":"Nat Rev Cancer"},{"key":"3753_CR44","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","volume":"375","author":"GN Hortobagyi","year":"2016","unstructured":"Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, et al. Ribociclib as first-line therapy for HR-positive, advanced breast cancer. N Engl J Med. 2016;375:1738\u201348.","journal-title":"N Engl J Med"},{"key":"3753_CR45","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1200\/JCO.20.02514","volume":"38","author":"SRD Johnston","year":"2020","unstructured":"Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, et al. Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2\u2212, node-positive, high-risk, early breast cancer (monarchE). J Clin Oncol. 2020;38:3987\u201398.","journal-title":"J Clin Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03753-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:02:28Z","timestamp":1777932148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03753-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":45,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,5,26]]}},"alternative-id":["3753"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03753-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Medical Ethics Committee and the Animal Welfare and Ethics Committee of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University (ID: 2022-67201 and 2021-07090), and all procedures were conducted in strict accordance with their guidelines and relevant regulations. Informed consent was obtained from all participants. All experiments involving mice were performed in strict compliance with the guidelines of the National Research Council (US) Committee for the Welfare and Ethical Treatment of Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}]}}